The GLP-1 medications liraglutide and semaglutide, as well as the dual GLP-1 and glucose-independent insulinotropic polypeptide (GIP) tirzepatide, are approved by the U.S
Unlike existing SGLT2 inhibitors, which solely reduce blood glucose levels by blocking the reabsorption of glucose in the renal tubules, celastrol can exert its effects through multiple pathways, such as anti-inflammation, anti-oxidation, anti-fibrosis, and the regulation of ferroptosis and lipid metabolism
Clinical utility of phentermine/topiramate (Qsymia) combination for the treatment of obesity
Ongoing support is available through the Omzo app and care team
Pregnancy increases caloric needs by approximately 200 calories daily in the third trimester, but requirements vary individually